NFYB and melanoma: However, these CPD hotspots are not associated with elevated mutation density in melanoma (Fig. 2c), presumably because elevated CPD levels at NFYA/NFYB binding sites primarily occur at TT dipyrimidine sequences, which are typically not mutagenic.